Celgene (NASDAQ:CELG) Insider Robert J. Hugin unloaded 158,000 shares of Celgene stock on the open market in a transaction dated Monday, November 3rd. The stock was sold at an average price of $106.68, for a total transaction of $16,855,440.00. Celgene Corporation (NASDAQ:CELG) belongs to Healthcare sector. Its net profit margin is 21.80% and weekly performance is -0.60%. On last trading day company shares ended up $106.45. Celgene Corporation (NASDAQ:CELG) distance from 50-day simple moving average (SMA50) is 11.50%. Marathon Oil Corporation (NYSE:MRO) announced that John R. (J.R.) Sult, executive vice president and chief finance officer, will present at the Bank of America Merrill Lynch 2014 Global Energy Conference on Thursday, Nov. 13, 2014, at 4:20 p.m. EST. Marathon Oil Corporation (NYSE:MRO) shares increased 0.15% in last trading session and ended the day at $34.39. MRO Gross Margin is 65.60% and its return on assets is 7.30%. Marathon Oil Corporation (NYSE:MRO) quarterly performance is -11.59%. Avino Silver & Gold Mines Ltd. (NYSEMKT:ASM announce that its third quarter 2014 financial results will be released on Wednesday, November 12, 2014, after the market close. On 07 November, Avino Silver & Gold Mines Ltd. (NYSEMKT:ASM) shares increased 5.93% and was closed at $1.25. ASM EPS growth in last 5 year was 17.10%. Avino Silver & Gold Mines Ltd. (NYSEMKT:ASM) year to date (YTD) performance is 6.84%. RenaissanceRe Holdings (NYSE:RNR)‘s stock had its “sell” rating reiterated by research analysts at Deutsche Bank in a report released on Friday. They currently have a $96.00 price target on the stock. Deutsche Bank’s target price would suggest a potential downside of 5.24% from the company’s current price. RenaissanceRe Holdings Ltd. (NYSE:RNR) ended the last trading day at $101.58. Company weekly volatility is calculated as 1.66% and price to cash ratio as 13.98. RenaissanceRe Holdings Ltd. (NYSE:RNR) showed a weekly performance of -1.69%. On Nov. 4, Revance Therapeutics, Inc. (NASDAQ:RVNC) announced that its management is scheduled to participate in the Credit Suisse 2014 Healthcare Conference in Phoenix, Arizona. Revance management is scheduled to present on Thursday, November 13, 2014 at 8:30 am MT/10:30 am ET. Revance Therapeutics, Inc. (NASDAQ:RVNC) shares fell -1.25% in last trading session and ended the day at $19.79. RVNC return on assets is -38.40%. Revance Therapeutics, Inc. (NASDAQ:RVNC) quarterly performance is -22.51%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
